Announcements Trials
Browse Landscape

Phase

Phase 2 2

Status

Unknown 16Completed 15Recruiting 3Terminated 2Withdrawn 1Active not recruiting 1

Sponsor Class

INDUSTRY 243OTHER 240NIH 29NETWORK 14OTHER_GOV 2FED 1

Study Type

Interventional 2

Sponsor

Cancer Type

Gastrointestinal 1Breast 1

Conditions

Breast Neoplasms 6Colorectal Neoplasms 4Prostatic Neoplasms 3Pancreatic Neoplasms 3Neoplasms 3Stomach Neoplasms 2Small Cell Lung Carcinoma 2Sarcoma, Kaposi 2Rectal Neoplasms 2Neoplasm Metastasis 2Multiple Myeloma 2Lung Neoplasms 2Inflammatory Bowel Diseases 2Head and Neck Neoplasms 2HIV Infections 2Colonic Neoplasms 2Carcinoma, Renal Cell 2Uterine Cervical Neoplasms 1Urinary Tract Infections 1Triple Negative Breast Neoplasms 1Tongue Neoplasms 1Stomatitis 1Squamous Cell Carcinoma of Head and Neck 1Solid Tumor 1Renal Insufficiency 1Recurrence 1Radiation Injuries 1Prostatic Diseases 1Precursor Cell Lymphoblastic Leukemia-Lymphoma 1Postoperative Complications 1

Interventions

Tamoxifen 1Irinotecan 1Capecitabine 1

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

2 trials
RecentStart dateEnrollment
Terminated × OTHER_GOV × Neoplasm Metastasis × Clear all
NCT00532454 2010-02-10

Evaluation of the Association Between CYP2D6 Genetic Polymorphisms and the Treatment Effect of Tamoxifen

National Cancer Center, Korea

Phase 2 Terminated
21 enrolled
Breast

Breast Neoplasms, Neoplasm Metastasis

NCT00506168 2007-07-25

Study of Irinotecan & Capecitabine in Metastatic Colorectal Cancer

National Cancer Center, Korea

Phase 2 Terminated
37 enrolled
Gastrointestinal

Neoplasm Metastasis, Colorectal Neoplasms

Data powered by HemOnc (CC BY 4.0) Colophon âš¡